Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02046811 · ClinicalTrials.gov registry record · NA

Reducing Skin Cancer Risk in Childhood Cancer Survivors

A NA study of Skin Neoplasms, sponsored by Harvard School of Public Health (HSPH).

Completed
Registry status
NA
Development phase
726
Enrollment target
1
Study location

NCT02046811 is a NA study of Skin Neoplasms that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 726 participants, above the 479-participant average among 5 other Skin Neoplasms trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02046811, a NA study of Skin Neoplasms, has completed, sponsored by Harvard School of Public Health (HSPH).

COMPLETED
Registry status
NA
Development phase
726 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine the impact of a 12-month patient activation and education intervention on skin cancer early detection practices among childhood cancer survivors treated with radiation. This randomized controlled trial uses a three-group design. Our specific aims are to: (1) Determine the impact of a Patient Activation and Education intervention with and without physician activation and teledermatology on skin cancer early detection practices, (2) Determine the impact of the intervention on time to diagnosis, and (3) Estimate the cost and cost-effectiveness of the intervention as a secondary outcome.

Conditions Studied

Skin Neoplasms

Interventions

  • BEHAVIORAL Patient activation and education (PAE)
  • BEHAVIORAL PAE plus physician activation (PAE + MD)
  • BEHAVIORAL PAE physician activation, plus teledermoscopy (PAE +MD +TD)

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 726 participants
Start Date 2015-03
Est. Completion 2018-01-01
Phase NA

Sponsor

Harvard School of Public Health (HSPH)

40 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02046811

The ClinicalTrials.gov registry entry for NCT02046811 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 726 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 479-participant average among 5 other Skin Neoplasms trials with a reported enrollment target (52% higher). The listed sponsor is Harvard School of Public Health (HSPH), which has 40 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Skin Neoplasms appearing as the primary indexed condition, and to 3 interventions - of which Patient activation and education (PAE) is the first listed.

NCT02046811 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT02046811 about?

NCT02046811 is a clinical study titled "Reducing Skin Cancer Risk in Childhood Cancer Survivors". The objective of this study is to determine the impact of a 12-month patient activation and education intervention on skin cancer early detection practices among childhood cancer survivors treated with radiation. This randomized controlled trial uses a three-group design. Our specific aims are to: ...

What is the current status of trial NCT02046811?

This trial is currently completed. It is a NA study. The enrollment target is 726 participants. The study started on 2015-03. Estimated completion is 2018-01-01.

What conditions does trial NCT02046811 study?

This clinical trial studies the following conditions: Skin Neoplasms.

What interventions are being tested in trial NCT02046811?

The interventions under investigation include: Patient activation and education (PAE) (BEHAVIORAL), PAE plus physician activation (PAE + MD) (BEHAVIORAL), PAE physician activation, plus teledermoscopy (PAE +MD +TD) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02046811?

This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02046811 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Skin Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Skin Neoplasms

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.